Commentary on “Pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors

Authors

  • Shubham Kumar Saveetha University, Saveetha Institute of Medical and Technical Sciences, Chennai, India https://orcid.org/0009-0000-7690-950X
  • Rachana Mehta Manav Rachna International Institute of Research and Studies, Faridabad, India
  • Ranjana Sah Dr. D. Y. Patil Vidyapeeth (Deemed-to-be-University), Dr. D. Y. Patil Medical College Hospital and Research Centre, Maharashtra, India

DOI:

https://doi.org/10.1590/

Downloads

Download data is not yet available.

Downloads

Published

2025-01-27

Issue

Vol. 80 (2025)

Section

Correspondence

License

Copyright (c) 2025 Clinics

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Kumar, S., Mehta, R., & Sah, R. (2025). Commentary on “Pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors. Clinics, 80, 100651. https://doi.org/10.1590/